Detalhe da pesquisa
1.
Light-Induced Liposomal Drug Delivery with an Amphiphilic Porphyrin and Its Chlorin and Bacteriochlorin Analogues.
Mol Pharm
; 21(2): 609-621, 2024 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38189667
2.
Optically Controlled Drug Release from Light-Sensitive Liposomes with the New Photosensitizer 5,10-DiOH.
Mol Pharm
; 17(8): 2779-2788, 2020 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32543848
3.
Light-Controlled Delivery of Monoclonal Antibodies for Targeted Photoinactivation of Ki-67.
Mol Pharm
; 12(9): 3272-81, 2015 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26226545
4.
Chlorin-Based Photoactivable Galectin-3-Inhibitor Nanoliposome for Enhanced Photodynamic Therapy and NK Cell-Related Immunity in Melanoma.
ACS Appl Mater Interfaces
; 11(45): 41829-41841, 2019 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31617343
5.
A light-controlled switch after dual targeting of proliferating tumor cells via the membrane receptor EGFR and the nuclear protein Ki-67.
Sci Rep
; 6: 27032, 2016 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27246531
6.
Elevation of plasma membrane permeability by laser irradiation of selectively bound nanoparticles.
J Biomed Opt
; 10(6): 064012, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16409077
7.
Ki-67 as a molecular target for therapy in an in vitro three-dimensional model for ovarian cancer.
Cancer Res
; 70(22): 9234-42, 2010 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21045152